Authors:
Li, DN
Seidel, A
Pritchard, MP
Wolf, CR
Friedberg, T
Citation: Dn. Li et al., Polymorphisms in P450CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol, PHARMACOGEN, 10(4), 2000, pp. 343-353
Authors:
Friedberg, T
Pritchard, MP
Bandera, M
Hanlon, SP
Yao, D
McLaughlin, LA
Ding, S
Burchell, B
Wolf, CR
Citation: T. Friedberg et al., Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: An intralaboratory comparison, DRUG METAB, 31(2), 1999, pp. 523-544
Authors:
Li, DN
Pritchard, MP
Hanlon, SP
Burchell, B
Wolf, CR
Friedberg, T
Citation: Dn. Li et al., Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism, J PHARM EXP, 289(2), 1999, pp. 661-667
Authors:
Koenigs, LL
Peter, RM
Hunter, AP
Haining, RL
Rettie, AE
Friedberg, T
Pritchard, MP
Shou, M
Rushmore, TH
Trager, WF
Citation: Ll. Koenigs et al., Electrospray ionization mass spectrometric analysis of intact cytochrome P450: Identification of tienilic acid adducts to P450 2C9, BIOCHEM, 38(8), 1999, pp. 2312-2319
Authors:
Friedberg, T
Henderson, CJ
Pritchard, MP
Wolf, CR
Citation: T. Friedberg et al., In vivo and in vitro recombinant DNA technology as a powerful tool in drugdevelopment, HANDBOOK OF DRUG METABOLISM, 1999, pp. 321-362